J. Michael Pearson
2011 - Valeant Pharmaceuticals International
In 2011, J. Michael Pearson earned a total compensation of $36.7M as Chief Executive Officer at Valeant Pharmaceuticals International, a 672% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $2,996,825 |
|---|---|
| Option Awards | $6,015,000 |
| Salary | $1,578,462 |
| Stock Awards | $12,168,384 |
| Other | $13,951,315 |
| Total | $36,709,986 |
Pearson received $14M in other compensation, accounting for 38% of the total pay in 2011.
Pearson also received $3M in non-equity incentive plan, $6M in option awards, $1.6M in salary and $12.2M in stock awards.
Rankings
In 2011, J. Michael Pearson's compensation ranked 18th out of 10,747 executives tracked by ExecPay. In other words, Pearson earned more than 99.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 18 out of 10,747 | 100th |
Division Manufacturing | 5 out of 3,958 | 100th |
Major group Chemicals And Allied Products | 1 out of 1,031 | 100th |
Industry group Drugs | 1 out of 779 | 100th |
Industry Pharmaceutical Preparations | 1 out of 567 | 100th |
Source: SEC filing on April 22, 2014.
Pearson's colleagues
We found six more compensation records of executives who worked with J. Michael Pearson at Valeant Pharmaceuticals International in 2011.
2011
Howard Schiller
Valeant Pharmaceuticals International
Chief Financial Officer
2011
Brian Stolz
Valeant Pharmaceuticals International
Executive Vice President of Administration and Chief Human Capital Officer
2011
Rajiv De Silva
Valeant Pharmaceuticals International
Chief Operating Officer
2011
Mark Durham
Valeant Pharmaceuticals International
Senior Vice President, Human Resources
2011
Robert Chai-Onn
Valeant Pharmaceuticals International
Chief Legal Officer
2011
Philip Loberg
Valeant Pharmaceuticals International